MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹9.76 Cr |
| Mar2023 | ₹6.66 Cr |
| Mar2022 | ₹2.64 Cr |
| Mar2021 | ₹0.93 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | 87.61 | |
| Mar2024 | ₹9.76 Cr | 46.52 | |
| Mar2023 | ₹6.66 Cr | 152.33 | |
| Mar2022 | ₹2.64 Cr | 184.90 | |
| Mar2021 | ₹0.93 Cr | - | |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,922.7 Cr | 16.8% | 52.4% | 78.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 16.8% |
52.4% |
78.5% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses